QA: Arcutis Biotherapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001787306_2023_Arcutis_Biotherapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001787306, Arcutis Biotherapeutics Inc.

  xvar xval
0 AssetsCurrent 437,406,000
1 IntangibleAssetsNetIncludingGoodwill 7,188,000
2 PropertyPlantAndEquipmentNet 1,881,000
3 remainder_Assets 2,799,000
4 LiabilitiesCurrent 37,807,000
5 LiabilitiesNoncurrent 201,886,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 122,124,000
9 ResearchAndDevelopmentExpense 182,435,000
10 remainder_Expenses 754,000
11 remainder_Revenues 3,686,000
12 remainder_NetIncome -9,831,000
13 remainder_ComprehensiveNetIncome -831,000
  yvar yval
0 Assets 449,274,000
1 Liabilities 239,693,000
2 Expenses 305,313,000
3 Revenues 3,686,000
4 StockholdersEquity 209,581,000
5 NetIncome -311,458,000
6 ComprehensiveNetIncome -311,873,500
7 BaseVar 504,314,000
8 EconomicCapitalRatio 0.141

Edgar->Model Mapping

Feature Distribution

Change over Time